IL21 and rheumatoid arthritis: Nevertheless, Kwok et al. and Chen et al. revealed that active RA patients had enlarged serum levels of IL-21, but when patients were in remission after anti-TNF-α therapy, their serum levels of IL-21 were meaningfully decreased [45,46].